During the past decade, Graves-Gilbert Clinic conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 18 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 10 clinical trials were completed. i.e. 333.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Graves-Gilbert Clinic" #1 sponsor was "SCRI Development Innovations, LLC" with 8 trials, followed by "Gilead Sciences" with 7 trials sponsored, "Pfizer" with 5 trials sponsored, "Jazz Pharmaceuticals" with 4 trials sponsored and "Genentech, Inc." with 4 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Graves-Gilbert Clinic" #1 collaborator was "Genentech, Inc." with 4 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Quintiles, Inc." with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Graves-Gilbert Clinic" are "Rheumatoid Arthritis" (11 trials), "Arthritis, Rheumatoid" (4 trials), "Hepatitis C, Chronic" (4 trials), "Chronic Hepatitis C" (3 trials) and "Fibromyalgia" (3 trials). Many other conditions were trialed in "Graves-Gilbert Clinic" in a lesser frequency.

Most popular intervention types in "Graves-Gilbert Clinic" are "Drug" (40 trials), "Biological" (7 trials), "Other" (3 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Bevacizumab" (3 trials), "Gemcitabine" (3 trials), "RBV" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Graves-Gilbert Clinic" are 50 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Graves-Gilbert Clinic". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Graves-Gilbert Clinic, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Graves-Gilbert Clinic, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".